← FDA Drug Approvals (Drugs@FDA)

IRINOTECAN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2010-04-15

Drug application

FDA Application #

ANDA078953

Application type

Abbreviated New Drug Application (Generic)

Brand name

IRINOTECAN HYDROCHLORIDE

Generic name

Irinotecan Hydrochloride

Active ingredients

IRINOTECAN HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

CHARTWELL RX

First approval

2010-04-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown